BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1034 related articles for article (PubMed ID: 21187858)

  • 1. NF-κB and STAT3 - key players in liver inflammation and cancer.
    He G; Karin M
    Cell Res; 2011 Jan; 21(1):159-68. PubMed ID: 21187858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-inflammatory NHE-06 restores antitumor immunity by targeting NF-κB/IL-6/STAT3 signaling in hepatocellular carcinoma.
    Lu X; Wo G; Li B; Xu C; Wu J; Jiang C; Wei J
    Biomed Pharmacother; 2018 Jun; 102():420-427. PubMed ID: 29574282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Positive Feedback Loop of AKR1C3-Mediated Activation of NF-κB and STAT3 Facilitates Proliferation and Metastasis in Hepatocellular Carcinoma.
    Zhou Q; Tian W; Jiang Z; Huang T; Ge C; Liu T; Zhao F; Chen T; Cui Y; Li H; Yao M; Li J; Tian H
    Cancer Res; 2021 Mar; 81(5):1361-1374. PubMed ID: 33361392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.
    Kang HJ; Chung DH; Sung CO; Yoo SH; Yu E; Kim N; Lee SH; Song JY; Kim CJ; Choi J
    Oncotarget; 2017 Apr; 8(16):27263-27276. PubMed ID: 28460481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
    Ding H; Zhang X; Su Y; Jia C; Dai C
    Cell Mol Biol Lett; 2020; 25():8. PubMed ID: 32123532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
    Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
    EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation.
    He G; Yu GY; Temkin V; Ogata H; Kuntzen C; Sakurai T; Sieghart W; Peck-Radosavljevic M; Leffert HL; Karin M
    Cancer Cell; 2010 Mar; 17(3):286-97. PubMed ID: 20227042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
    Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
    Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic inflammation and hepatocellular carcinoma.
    Alison MR; Nicholson LJ; Lin WR
    Recent Results Cancer Res; 2011; 185():135-48. PubMed ID: 21822824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
    Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
    Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
    [No Abstract]   [Full Text] [Related]  

  • 11. CD8
    Xu C; Lu X; Liu W; Chen A; Meng G; Zhang H; Li B; Zhang Y; Wu J; Wei J
    J Transl Med; 2018 May; 16(1):132. PubMed ID: 29784005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
    Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
    Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual role for inositol-requiring enzyme 1α in promoting the development of hepatocellular carcinoma during diet-induced obesity in mice.
    Wu Y; Shan B; Dai J; Xia Z; Cai J; Chen T; Lv S; Feng Y; Zheng L; Wang Y; Liu J; Fang J; Xie D; Rui L; Liu J; Liu Y
    Hepatology; 2018 Aug; 68(2):533-546. PubMed ID: 29506314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of liver cancer.
    Pan H; Fu X; Huang W
    Anticancer Agents Med Chem; 2011 Jul; 11(6):493-9. PubMed ID: 21554201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation.
    Zhang W; Zhangyuan G; Wang F; Jin K; Shen H; Zhang L; Yuan X; Wang J; Zhang H; Yu W; Huang R; Xu X; Yin Y; Zhong G; Lin A; Sun B
    Immunity; 2021 Jun; 54(6):1168-1185.e8. PubMed ID: 34038747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals.
    da Silva CG; Studer P; Skroch M; Mahiou J; Minussi DC; Peterson CR; Wilson SW; Patel VI; Ma A; Csizmadia E; Ferran C
    Hepatology; 2013 May; 57(5):2014-25. PubMed ID: 23238769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Biejia Jianwan decoction restrains PD-L1-mediated immune evasion through the HIF-1α/STAT3/NF-κB signaling pathway.
    Tian X; Liu F; Wang Z; Zhang J; Liu Q; Zhang Y; Zhang D; Huang C; Zhao J; Jiang S
    J Ethnopharmacol; 2024 Mar; 322():117577. PubMed ID: 38104877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and liver cancer: new molecular links .
    Berasain C; Castillo J; Perugorria MJ; Latasa MU; Prieto J; Avila MA
    Ann N Y Acad Sci; 2009 Feb; 1155():206-21. PubMed ID: 19250206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinoma.
    Ma W; Sze KM; Chan LK; Lee JM; Wei LL; Wong CM; Lee TK; Wong CC; Ng IO
    Oncotarget; 2016 Jul; 7(27):41445-41459. PubMed ID: 27213590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer.
    Fan Y; Mao R; Yang J
    Protein Cell; 2013 Mar; 4(3):176-85. PubMed ID: 23483479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.